Dr. Samuel Frank

Samuel Frank, MD is the Director of Clinical Research Network Development and a movement disorder neurologist at Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital for Harvard Medical School. Dr. Frank was the principal investigator for the Huntington Study Group (HSG) studies of deutetrabenzaine, First-HD, ARC- HD, and a site investigator for many HD trials. He served as an investigator on the HSG executive committee and co-chair of the HSG Executive Membership Committee. He was a member of the National Huntington Disease Society of America (HDSA) Board of Trustees and serves locally as the director of the HDSA Center of Excellence at BIDMC. Dr. Frank is the inpatient neurology consultant for the specialized Huntington’s Disease service at Tewksbury Hospital and the Chair of the Experimental Neurotherapeutics section of the American Academy of Neurology.